447
Participants
Start Date
June 2, 2021
Primary Completion Date
December 17, 2024
Study Completion Date
December 17, 2024
Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
MOUD for OUD
HIV testing
HIV testing
HIV treatment for participants living with HIV not already in care
HIV treatment for participants living with HIV not already in care
PrEP for participants without HIV
PrEP for participants without HIV
Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV)
Testing and referral for vaccination or treatment for HAV and HBV
Testing and referral for treatment for hepatitis C virus (HCV)
Testing and referral for treatment for HCV
Sexually transmitted infection (STI) testing and treatment
STI testing and treatment
Primary care
Primary care
Harm reduction services
Harm reduction services
Peer navigation
Peer navigation
COVID-19 testing and referral for further evaluation, care and/or treatment
COVID-19 testing and referral for further evaluation, care and/or treatment
Bronx Prevention Center CRS, The Bronx
Penn Prevention CRS, Philadelphia
George Washington University CRS, Washington D.C.
Houston AIDS Research Team CRS, Houston
UCLA Vine Street Clinic, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Institute on Drug Abuse (NIDA)
NIH
HIV Prevention Trials Network
NETWORK